Associate Professor, Urology, University of Michigan Medical School
Urology
Dr. Ganesh S. Palapattu, MD
|
|
Give Review
Ganesh Palapattu works in the field of Urology. He graduated from Baylor College of Medicine. He received 3 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Doctor Ganesh S. Palapattu, MD has written publications. He has 85 publications published with PubMed. The lastest paper is: 'The association of selected pathological features with prostate cancer in a single-needle biopsy accession.' Doctor Ganesh S. Palapattu, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Prognostic value of percent Gleason grade 4 at Prostate biopsy on predicting Prostatectomy pathology and recurrence.
- Clinicopathologic characteristics of anterior prostate Cancer (APC), including correlation with previous biopsy pathology.
- Preparing Patients and Partners for the Recovery From the Side-Effects of Prostate Cancer Surgery: a Group Approach.
- Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk-Stratification Algorithm Based on Percutaneous Renal Mass Biopsy and Mass Size for A...
- Molecular and Immunohistochemical Characterization Reveals Novel BRAF Mutations in Metanephric Adenoma.
- What Couples Say about Their Recovery of Sexual Intimacy after Prostatectomy: Toward the Development of a Conceptual Model of Couples' Sexual Recovery after Surgery fo...
- Delivering Enhanced Testosterone Replacement Therapy through Nanochannels.
- HRAS mutations are frequent in inverted urothelial neoplasms.
- Mass-like peripheral zone enhancement on CT is predictive of higher-grade (Gleason 4 + 3 and higher) prostate Cancer.
- Understanding the Relationship Between Tumor Size, Gland Size, and Disease Aggressiveness in Men With Prostate Cancer.
- Exploring the role of the partner in couples' sexual recovery after surgery for prostate Cancer.
- Papillary renal cell Carcinoma revisited: a comprehensive histomorphologic study with outcome correlations.
- Metabolomic Profiling Identifies Biochemical Pathways Associated with Castration-Resistant Prostate Cancer.
- Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate Cancer after salvage radia...
- Validated RP-HPLC Method for the Simultaneous Analysis of Gemcitabine and LY-364947 in Liposomal Formulations.
- Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate Cancer-specific death in patients receiving salvage radiation therapy f...
- The role of sarcosine metabolism in prostate Cancer progression.
- Erratum to: Characterization of nanochannel delivery membrane systems for the sustained release of resVeratrol and atorvastatin: new perspectives on promoting heart he...
- Characterization of nanochannel delivery membrane systems for the sustained release of resVeratrol and atorvastatin: new perspectives on promoting heart health.
- Combining T-cell immunotherapy and anti-androgen therapy for prostate Cancer.
- Certificate of need programs, intensity modulated radiation therapy use and the cost of prostate Cancer care.
- Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression.
- Metabolomic profiling reveals a role for androgen in activating amino Acid metabolism and methylation in prostate Cancer cells.
- Label-free high-resolution imaging of prostate Glands and cavernous nerves using coherent anti-Stokes Raman scattering microscopy.
- A novel in vitro assay of tumor-initiating cells in xenograft Prostate tumors.
- The impact of HMG-CoA reductase therapy on serum PSA.
- Utilization of pharmacotherapy for erectile dysfunction following treatment for prostate Cancer.
- Controversies surrounding lymph node dissection for prostate Cancer.
- Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder Cancer.
- Selective expression of CD44, a putative prostate Cancer stem cell marker, in neuroendocrine tumor cells of human prostate Cancer.
- CD44 expression is a feature of prostatic small cell Carcinoma and distinguishes it from its mimickers.
- Prostate-specific antigen levels in relation to consumption of nonsteroidal anti-inflammatory drugs and acetaminophen: results from the 2001-2002 National Health and N...
- Prostate-specific antigen levels in relation to cadmium exposure and zinc intake: results from the 2001-2002 National Health and Nutrition Examination Survey.
- CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate Cancer.
- Multiple biomarkers improve prediction of bladder Cancer recurrence and mortality in patients undergoing cystectomy.
- Mucinous tubular and spindle cell Carcinoma of the kidney with sarcomatoid differentiation.
- Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection.
- Prognostic value of preoperative serum cell-free circulating DNA in men with prostate Cancer undergoing radical prostatectomy.
- PSA screening and elderly men.
- Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
- Nomograms provide improved accuracy for predicting survival after radical cystectomy.
- Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the Bladder.
- Characteristics and outcomes of patients with Carcinoma in situ only at radical cystectomy.
- Epithelial architectural destruction is necessary for bone marrow derived cell contribution to regenerating Prostate epithelium.
- Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the Bladder compared to transitional cell carcinoma of the Bladder.
- Do prostate Cancer patients at risk of pelvic lymph-node metastasis benefit from pelvic radiation?
- Lymphovascular invasion is independently associated with overall survival, cause-Specific survival, and local and distant recurrence in patients with negative lymph no...
- Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early Prostate-specific antigen recurrence following radical Prostatectomy.
- Preoperative somatic symptoms are associated with disease progression in patients with Bladder carcinoma after cystectomy.
- Assessment of perioperative psychological distress in patients undergoing radical cystectomy for bladder Cancer.
- Anatomical extent of lymph node dissection: impact on men with clinically localized prostate Cancer.
- Prostate specific antigen progression in men with lymph node metastases following radical Prostatectomy: results of long-term followup.
- Willard E. Goodwin: educator, innovator and pioneer.
- Collecting system invasion in renal cell Carcinoma: impact on prognosis and future staging strategies.
- Advances in the Treatment of Genitourinary Cancer: Highlights from the 3rd Annual Meeting of the Society of Urologic Oncology, December 13-14, 2002, Washington, DC.
- Lymph node dissection in patients with kidney Cancer: when is it indicated?
- Monoclonal antibody therapy for genitourinary oncology: promise for the future.
- Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell Carcinoma.
- A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate Cancer-specific death for patients receiving salvage radiation therapy...
- Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis.
- A simple inexpensive snare for manipulation of intravesical foreign bodies.
- Conservative management of a grade 4 renal laceration in a child.
- Acute bilateral renal cortical necrosis as a cause of postoperative renal failure.
- Prostate stem cell antigen is overexpressed in human transitional cell Carcinoma.
- Resolution of the Chronic pelvic pain syndrome after renal transplantation.
- Gene therapy for prostate Cancer. New perspectives on an old problem.
- The association of selected pathological features with prostate Cancer in a single-needle biopsy accession.
- Transgenic mouse models for tumor suppressor genes.
- Prostate carcinogenesis and inflammation: emerging insights.
- Molecular biomarker in prostate Cancer: the role of CpG island hypermethylation.
- Cancer specific outcomes in patients with pT0 disease following radical cystectomy.
- Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.
- Precystectomy nomogram for prediction of advanced bladder Cancer stage.
- Concomitant Carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
- Advanced age is associated with poorer bladder Cancer-specific survival in patients treated with radical cystectomy.
- Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
- A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome.
- Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic Disease.
- Adjuvant chemotherapy for bladder Cancer does not alter Cancer-specific survival after cystectomy in a matched case-control study.
- Outcomes of patients with clinical T1 grade 3 urothelial cell Bladder carcinoma treated with radical cystectomy.
- Editorial comment on: Bladder and urethral sphincter function after radical retropubic prostatectomy: a prospective long-term study.
- Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder Cancer.
- Neoadjuvant therapy preceding prostatectomy for prostate Cancer: rationale and current trials.
- Independent Surgical Validation of the New Prostate Cancer Grade Grouping System.
Schools
Baylor Coll Of Med
Procedures Preformed
- Adrenalectomy
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Complete Nephrectomy With Robotic Assistance
- Cystotomy
- View All
Conditions Treated
- Adrenal Gland Cancer
- Anemia
- Bladder Cancer
- Bladder Infection
- View All
Doctors Specialties
- Cancer Research
- Oncology
- Surgical Oncology
- Urologic Oncology
- Urology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
UCLA Medical Center -
Baylor College of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1124074786 | |
| NPPES Provider LastName | PALAPATTU | |
| NPPES Provider FirstName | GANESH | |
| NPPES Provider ZIPCode | 481095913 | |
| NPPES Provider State | MI | |
| Specialty Description | Urology | |
| Total Claim Count | 94.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1124074786 |
| Last Name Of The Provider | PALAPATTU |
| First Name Of The Provider | GANESH |
| View All |
Similar Doctors
|
|
Dr. Ted A. Skolarus, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard R. Usitalo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ann L. Oldendorf, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brent K. Hollenbeck, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. James E. Montie, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. David C. Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl VanAppledorn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey S. Montgomery, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cheryl T. Lee, MD |
|
|
Dr. Christopher P. Filson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Noah E. Canvasser, MD |
|
|
Dr. Jaclyn C. Milose, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kate H. Kraft, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey C. Wheat, MD |
|
|
Dr. Sara M. Lenherr, MD
This Doctor is OpenDoctor Recommended.
|